152 related articles for article (PubMed ID: 38451420)
1. A Prospective, Monocentric Case-Control Study on Uncontrolled Psoriasis as Independent Risk Factor for a Hypercoagulable State.
Hillary TM; Vanhoutvin T; Peeters M; Imbrechts M; Vanassche T; Garmyn M; Vermeire S
Dermatol Ther (Heidelb); 2024 Mar; 14(3):767-775. PubMed ID: 38451420
[TBL] [Abstract][Full Text] [Related]
2. Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
Detrez I; Thomas D; Van Steen K; Ballet V; Peeters M; Hoylaerts MF; Van Assche G; Vermeire S; Ferrante M; Gils A
J Clin Gastroenterol; 2020 Oct; 54(9):819-825. PubMed ID: 31789759
[TBL] [Abstract][Full Text] [Related]
3. Measurement of circulating miRNA-125a exhibits good value in the management of etanercept-treated psoriatic patients.
Pei D; Cao J; Qin G; Wang X
J Dermatol; 2020 Feb; 47(2):140-146. PubMed ID: 31820498
[TBL] [Abstract][Full Text] [Related]
4. Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study.
Li B; Li G; Song Z; Zhang Z
Rheumatol Ther; 2023 Feb; 10(1):149-160. PubMed ID: 36271188
[TBL] [Abstract][Full Text] [Related]
5. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
6. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
7. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
[TBL] [Abstract][Full Text] [Related]
8. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
9. The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
Bollen L; Vande Casteele N; Peeters M; Van Assche G; Ferrante M; Van Moerkercke W; Declerck P; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Nov; 21(11):2540-8. PubMed ID: 26313696
[TBL] [Abstract][Full Text] [Related]
10. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2022 May; 5(5):CD011535. PubMed ID: 35603936
[TBL] [Abstract][Full Text] [Related]
11. Short-term effect of infliximab is reflected in the clot lysis profile of patients with inflammatory bowel disease: a prospective study.
Bollen L; Vande Casteele N; Peeters M; Bessonov K; Van Steen K; Rutgeerts P; Ferrante M; Hoylaerts MF; Vermeire S; Gils A
Inflamm Bowel Dis; 2015 Mar; 21(3):570-8. PubMed ID: 25659086
[TBL] [Abstract][Full Text] [Related]
12. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
[TBL] [Abstract][Full Text] [Related]
13. Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study.
Montaudié H; Albert-Sabonnadière C; Acquacalda E; Fontas E; Danré A; Roux C; Ortonne JP; Lacour JP; Euller-Ziegler L; Passeron T
J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1186-91. PubMed ID: 23981008
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic Fatty Liver Disease Among Iraqi Patients With Psoriasis: A Case-Control Study.
Dhaher SA; Hilfi NZ; Abdullah MA
Cureus; 2024 Apr; 16(4):e57487. PubMed ID: 38707119
[TBL] [Abstract][Full Text] [Related]
15. A simple tool for evaluation of inflammation in psoriasis: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease.
Kommoss KS; Bieler T; Ringen J; Lehmann A; Mihalceanu S; Hobohm L; Keller K; Brand A; Fischer B; Kramer D; Wild J; Waisman A; Enk A; Schäkel K; Heikenwälder M; Karbach S
J Mol Med (Berl); 2024 Feb; 102(2):247-255. PubMed ID: 38127137
[TBL] [Abstract][Full Text] [Related]
16. Visualization of atherosclerosis as detected by coronary artery calcium and carotid intima-media thickness reveals significant atherosclerosis in a cross-sectional study of psoriasis patients in a tertiary care center.
Santilli S; Kast DR; Grozdev I; Cao L; Feig RL; Golden JB; Debanne SM; Gilkeson RC; Orringer CE; McCormick TS; Ward NL; Cooper KD; Korman NJ
J Transl Med; 2016 Jul; 14(1):217. PubMed ID: 27448600
[TBL] [Abstract][Full Text] [Related]
17. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Vanaclocha F; Crespo-Erchiga V; Jiménez-Puya R; Puig L; Sánchez-Carazo JL; Ferrán M; Sancho C; Juliá B; Cea-Calvo L; Marín-Jiménez I; García-Vicuña R;
Actas Dermosifiliogr; 2015; 106(1):35-43. PubMed ID: 25091923
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Hypertension, Diabetes, Lipid Disorders, Overweight/Obesity and Nicotine Dependence on Health-Related Quality of Life and Psoriasis Severity in Psoriatic Patients Receiving Systemic Conventional and Biological Treatment.
Karpińska-Mirecka A; Bartosińska J; Krasowska D
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948777
[TBL] [Abstract][Full Text] [Related]
20. Brodalumab Seems to Recover Its Therapeutic Efficacy After a Relatively Short "Washout" Period with Anti-TNF Agents: A Successful Pattern for Double-switch Therapy.
Tampouratzi E; Sfaelos K; Talaiporou K; Douvali Τ; Katsantonis J
Acta Dermatovenerol Croat; 2023 Aug; 31(1):48-50. PubMed ID: 37843093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
